Elias Zerhouni News
Most Popular Elias Zerhouni Story
New U.S. research program to target mystery diseases
The National Institutes of Health has created a new research program that is devoting itself to studying patients with mystery diseases. The Undiagnosed Diseases Program will start to accept cases
... Read more...Latest Headlines
- December 16, 2008
- September 30, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
